AGEs | advanced glycation end products |
DME | diabetic macular edema |
DR | diabetic retinopathy |
FGF21 | Fibroblast growth factor 21 |
NAFLD | nonalcoholic fatty liver disease |
NASH | nonalcoholic steatohepatitis |
PPARα | peroxisome proliferator-activator receptor alpha |
PKC | protein kinase C |
PEA | palmitoylethanolamide |
SPPARMα | selective peroxisome proliferator-activated receptor alpha modulator |
VEGF | vascular endothelial growth factor |
VAP-1 | vascular adhesion protein-1 |